XGN

Conviction 53HealthcareScan · Mon, Aug 10, 2026

Bearish engulfing

XGN$6.67-2.91%

ResistanceSupportVol 14

Vol MA14 491.96K

May 11May 28Jun 16Jul 6Jul 23Aug 10

EXAGEN INC.SERVICES-MEDICAL LABORATORIESwww.exagen.com ↗

Price6.67

Change-2.91%

Gap+0.29%

Rel volume0.79×

Avg volume424.04K

Avg $ vol2.45M

SMA 205.07

SMA 504.76

SMA 2005.10

Price vs 50+40.18%

Price vs 200+30.73%

MA stackmixed

50/200 cross—

Supertrendup · 5.18

RSI (14)72

MACD hist0.24

MACD crossbull · 4d

Stoch %K / %D86 / 87

ADX (14)30

+DI / −DI38 / 8

RSI divergence—

MACD divergence—

ATR %+7.17%

ADR %8.04%

52w high11.96

52w low2.65

From 52w high-44.23%

Above 52w low+151.70%

New 52w highNo

SqueezeOff

Bollinger width73.84%

%B0.93

Donchian pos85.90%

Donchian high7.10

Donchian low4.05

AVWAP (52w high)5.16

vs AVWAP high+29.37%

AVWAP (52w low)4.38

vs AVWAP low+52.14%

OBV trendUp

Chaikin MF (20)0.09

Today vs 20d0.79×

Avg vol (14d)491.96K

Avg vol (20d)424.04K

Avg $ vol (20d)2.45M

Market cap—

RS 3m (vs SPY)+127.98%

RS 6m (vs SPY)+90.35%

RS line new highYes

Trend template4/8

Technical rank92.6

1 week+42.52%

1 month+49.89%

3 months+126.10%

6 months+90.03%

1 year-25.81%

YTD+10.43%

P/E-8.34

P/B13.62

P/S2.50

P/FCF-11.67

EPS-0.9300

Div yield—

ROE-163.32%

ROA-38.42%

Debt/Eq1.87

Current3.18

EV/EBITDA-13.76

Gross margin58.28%

Net margin-29.97%

Rev growth19.65%

EPS growth-31.99%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value164.68M

Revenue19.94M

Net income-3.2M

Gross profit12.22M

Free cash flow-14.27M

IndustrySERVICES-MEDICAL LABORATORIES

ExchangeNasdaq

Shares out24.16M

Employees220

ListedThu, Sep 19, 2019

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction53 / 100

Pattern quality—

Tech rank92.6 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish engulfing

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XGN

All disclosures →

No recent disclosed trades by Congress in XGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XGN · 3 buys

Insider	Side	Shares	Value	Traded	Filed
KAHN SCOTT D Director · Stock Option(right to buy) · 2026-06-09	Grant	37.5K	—	2026-06-09	2026-06-22
Stokes Frank Director · Stock Option(right to buy) · 2026-06-09	Grant	37.5K	—	2026-06-09	2026-06-22
McKhann Chas Director · Stock Option(right to buy) · 2026-06-09	Grant	37.5K	—	2026-06-09	2026-06-22

SEC filings

EDGAR filings in XGN · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.